Carrie Strom is Senior Vice President, AbbVie, and President, Global
Allergan Aesthetics and has served in this role since May 2020.
Prior to joining AbbVie, Carrie served as Senior Vice President of
U.S. Medical Aesthetics at Allergan® beginning in May 2018, overseeing
the aesthetic portfolio for the multi-billion dollar U.S. business
including the iconic brand BOTOX® Cosmetic
(onabotulinumtoxinA), the JUVEDERM® Collection of Fillers,
COOLSCULPTING® , COOLTONE™ and SKINMEDICA® among others.
Previously, Carrie was Vice President of Marketing, Plastic Surgery
and Regenerative Medicine at Allergan from June 2016. 2017 posted a
record-high growth rate, where she was instrumental in the $2.8B
acquisition and integration of LifeCell. Prior to that, Carrie led
SKINMEDICA® Marketing from 2014 and worked on BOTOX®
(onabotulinumtoxinA) Therapeutic in Urology and Neurology at Allergan
Before Allergan, Carrie spent over 10 years at Pfizer where she led
marketing for Lipitor® and held various other sales and marketing roles.
Carrie received a B.A. in Communications from the University of
Colorado, Boulder. She is an advocate for women in business and is
actively involved with the Girls Inc. organization. She serves on the
board of directors for Susan G. Komen of Orange County, CA and for
Octane in Southern California. Carrie lives in Newport Beach, CA with
her husband and two children.